{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:40:19Z","timestamp":1747154419791,"version":"3.40.5"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.advms.2018.12.007","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T05:05:45Z","timestamp":1551157545000},"page":"235-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Significance of BRCA1 expression in breast and ovarian cancer patients with brain metastasis \u2013 A multicentre study"],"prefix":"10.1016","volume":"64","author":[{"given":"Monika","family":"Szarszewska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Markowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Jach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Marsza\u0142ek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violetta","family":"Filas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wies\u0142awa","family":"Bednarek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Olejek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Tomczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Sajdak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Nowak-Markwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Jaszczy\u0144ska-Nowinka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Stanis\u0142awiak-Rudowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Grybo\u015b","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2784-7968","authenticated-orcid":false,"given":"Anita","family":"Chudecka-G\u0142az","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Grybo\u015b","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krystyna","family":"Adamska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodryg","family":"Ramlau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janina","family":"Markowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3008-616X","authenticated-orcid":false,"given":"Pawe\u0142","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.advms.2018.12.007_bib0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11912-011-0203-y","article-title":"Epidemiology of brain metastases","volume":"14","author":"Nayak","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.advms.2018.12.007_bib0010","doi-asserted-by":"crossref","first-page":"114","DOI":"10.12703\/P6-114","article-title":"Brain metastasis and treatment","volume":"6","author":"Ahluwalia","year":"2014","journal-title":"F1000Prime Rep"},{"issue":"11","key":"10.1016\/j.advms.2018.12.007_bib0015","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/neuonc\/nox077","article-title":"Incidence and prognosis of patients with brain metastases and diagnosis of systemic malignancy. A population-based study","volume":"19","author":"Cagney","year":"2017","journal-title":"Neuro Oncol"},{"issue":"7","key":"10.1016\/j.advms.2018.12.007_bib0020","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1097\/IGC.0000000000000489","article-title":"Epithelial ovarian Cancer Metastatic to the central nervous system and a family history concerning for hereditary breast and ovarian Cancer-A potential relationship","volume":"25","author":"Jernigan","year":"2015","journal-title":"Int J Gynecol Cancer"},{"issue":"2s","key":"10.1016\/j.advms.2018.12.007_bib0025","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.ijrobp.2016.06.153","article-title":"BRCA1 mutations associated with increased risk of brain metastases in breast cancer: a 2:1 matched-pair analysis","volume":"96","author":"Zavitsanos","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.advms.2018.12.007_bib0030","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/annonc\/mdi351","article-title":"Spectrum of breast cancer metastasis in BRCA1 mutation carriers: highly increased incidence of brain metastases","volume":"16","author":"Albiges","year":"2005","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.advms.2018.12.007_bib0035","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/cncr.25771","article-title":"Multifactorial central nervous system recurrence susceptibility in patients with HER2-positive breast cancer: epidemiological and clinical data from a population-based cancer registry study","volume":"117","author":"Musolinio","year":"2011","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.advms.2018.12.007_bib0040","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2217\/cns.12.37","article-title":"Strategies for overcoming the blood-brain barrier for the treatment of brain metastases","volume":"2","author":"Hu","year":"2013","journal-title":"CNS Oncol"},{"issue":"2","key":"10.1016\/j.advms.2018.12.007_bib0045","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1525-1438.2006.00547.x","article-title":"Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1","volume":"16","author":"Zhang","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.advms.2018.12.007_bib0050","first-page":"2764","article-title":"Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13","volume":"60","author":"Seraj","year":"2000","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.advms.2018.12.007_bib0055","first-page":"236","article-title":"BRMS1 inhibits expression of NF-kappaB subunit p65, uPA and OPN in ovarian cancer cells","volume":"35","author":"Sheng","year":"2014","journal-title":"Eur J Gynaecol Oncol"},{"issue":"8","key":"10.1016\/j.advms.2018.12.007_bib0060","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1158\/2159-8290.CD-12-0221","article-title":"Mechanisms of BRCA1 tumor suppression","volume":"2","author":"Silver","year":"2012","journal-title":"Cancer Discov"},{"issue":"15","key":"10.1016\/j.advms.2018.12.007_bib0065","article-title":"Activation of PI3K\/AKT\/mTOR pathway in ER+ breast cancer: Analysis of paired primary and metastatic tumor samples","volume":"33","author":"Pacheco","year":"2015","journal-title":"J Clin Oncol. ASCO Annual Meeting Proceedings"},{"issue":"5","key":"10.1016\/j.advms.2018.12.007_bib0070","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1634\/theoncologist.2014-0107","article-title":"Breast cancer with brain metastases: clinicopathologic features, survival, and paired biomarker analysis","volume":"20","author":"Shen","year":"2015","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.advms.2018.12.007_bib0075","first-page":"e246","article-title":"Molecular and genetic predictors of breast-to-Brain metastasis: review and case presentation","volume":"7","author":"Medress","year":"2015","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.advms.2018.12.007_bib0080","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10549-014-3237-7","article-title":"Prognostic factors of HER-2 positive breast cancer patients who develop brain metastasis: a multicenter retrospective analysis","volume":"149","author":"Hayashi","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.advms.2018.12.007_bib0085","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.2010.33.8889","article-title":"Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors","volume":"30","author":"Niikura","year":"2012","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.advms.2018.12.007_bib0090","first-page":"563","article-title":"Cerebral metastasis from ovarian cancer treated with a multidisciplinary approach. Case report and review of literature","volume":"24","author":"Porzio","year":"2003","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.advms.2018.12.007_bib0095","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/gyno.1995.1134","article-title":"Brain metastases in epithelial ovarian carcinoma","volume":"57","author":"Geisler","year":"1995","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.advms.2018.12.007_bib0100","first-page":"683","article-title":"Brain metastases from epithelial ovarian cancer-report of cases","volume":"30","author":"Stanis\u0142awiak","year":"2009","journal-title":"Eur J Gynaecol Oncol"},{"issue":"1","key":"10.1016\/j.advms.2018.12.007_bib0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2011.06.007","article-title":"Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells","volume":"311","author":"Chuang","year":"2011","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.advms.2018.12.007_bib0110","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1447-0756.2012.01961.x","article-title":"Increased incidence of brain metastases in BRCA1-related ovarian cancers","volume":"39","author":"Sekine","year":"2013","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"10.1016\/j.advms.2018.12.007_bib0115","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ygyno.2013.12.027","article-title":"Prognostic significance of the estrogen receptor beta (ER\u03b2) isoforms ER\u03b21, ER\u03b22, and ER\u03b25 in advanced serous ovarian cancer","volume":"132","author":"Ciucci","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.advms.2018.12.007_bib0120","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1023\/B:HIJO.0000032355.66152.b8","article-title":"CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion","volume":"35","author":"Kucia","year":"2004","journal-title":"J Mol Histol"},{"key":"10.1016\/j.advms.2018.12.007_bib0125","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1210\/me.2002-0438","article-title":"Stromal cell-derived factor-1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells","volume":"17","author":"Hall","year":"2003","journal-title":"Mol Endocrinol"},{"issue":"2","key":"10.1016\/j.advms.2018.12.007_bib0130","first-page":"23","article-title":"The role of chemokine receptor 4 and its ligand stromal cell derived factor 1 in breast cancer","volume":"3","author":"Aravindan","year":"2015","journal-title":"Ann Transl Med"},{"issue":"2","key":"10.1016\/j.advms.2018.12.007_bib0135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pharmthera.2007.01.010","article-title":"Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration","volume":"114","author":"Emdad","year":"2007","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.advms.2018.12.007_bib0140","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5858\/arpa.2013-0953-SA","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: american Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update","volume":"138","author":"Wolff","year":"2014","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"10.1016\/j.advms.2018.12.007_bib0145","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1158\/0008-5472.CAN-09-3838","article-title":"Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion","volume":"70","author":"Liu","year":"2010","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.advms.2018.12.007_bib0150","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/IGC.0b013e3182145561","article-title":"AEG -1 overexpression: a novel indicator for peritoneal dissemination and lymph node metastasis in epithelial ovarian cancers","volume":"21","author":"Li","year":"2011","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"10.1016\/j.advms.2018.12.007_bib0155","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1007\/s00432-017-2465-8","article-title":"Analysis of BRCA1\/2 mutation spectrum and prevalence in unselected Chinese breast cancer patients by next-generation sequencing","volume":"143","author":"Li","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.advms.2018.12.007_bib0160","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2478\/v10042-009-0085-0","article-title":"Increased serum level of membrane type 1-matrix metalloproteinase (MT1-MMP\/MMP-14) in patients with breast cancer","volume":"48","author":"Laudanski","year":"2010","journal-title":"Folia Histochem Cytobiol"},{"issue":"2","key":"10.1016\/j.advms.2018.12.007_bib0165","first-page":"193","article-title":"Protein kinase C involvement in proliferation and survival of breast cancer cells","volume":"40","author":"Jarzabek","year":"2002","journal-title":"Folia Histochem Cytobiol"},{"issue":"3","key":"10.1016\/j.advms.2018.12.007_bib0170","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ygyno.2016.09.025","article-title":"Brain metastases in patients with EOC: Clinicopathological and prognostic factors. A multicentric retrospective analysis from MITO group (MITO 19)","volume":"143","author":"Marchetti","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.advms.2018.12.007_bib0175","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Risch","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"7353","key":"10.1016\/j.advms.2018.12.007_bib0180","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Bell","year":"2011","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.advms.2018.12.007_bib0185","doi-asserted-by":"crossref","first-page":"7438","DOI":"10.1074\/jbc.M709446200","article-title":"Alterations of BRMS1 ARID 4A interaction modify gene expression but still suppress metastasis in human breast cancer cells","volume":"283","author":"Hurst","year":"2008","journal-title":"J Biol Chem"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S189611261830155X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S189611261830155X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T19:18:38Z","timestamp":1574709518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S189611261830155X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S189611261830155X"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2018.12.007","relation":{},"ISSN":["1896-1126"],"issn-type":[{"type":"print","value":"1896-1126"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significance of BRCA1 expression in breast and ovarian cancer patients with brain metastasis \u2013 A multicentre study","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2018.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}